PNC Financial Services Group’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.8K | Buy |
6,041
+3,537
| +141% | +$11.2K | ﹤0.01% | 3841 |
|
|
2025
Q4 | $10K | Buy |
2,504
+2,175
| +661% | +$12.1K | ﹤0.01% | 3949 |
|
|
2025
Q3 | $2.78K | Sell |
329
-135
| -29% | -$1.31K | ﹤0.01% | 4407 |
|
|
2025
Q2 | $5.22K | Buy |
464
+161
| +53% | +$1.48K | ﹤0.01% | 4114 |
|
|
2025
Q1 | $2.87K | Sell |
303
-112
| -27% | -$1.13K | ﹤0.01% | 4247 |
|
|
2024
Q4 | $4.67K | Sell |
415
-131
| -24% | -$2.3K | ﹤0.01% | 4058 |
|
|
2024
Q3 | $15.4K | Buy |
546
+445
| +441% | +$11.5K | ﹤0.01% | 3628 |
|
|
2024
Q2 | $1.93K | Sell |
101
-4,953
| -98% | -$126K | ﹤0.01% | 4261 |
|
|
2024
Q1 | $166K | Buy |
5,054
+4,548
| +899% | +$145K | ﹤0.01% | 2303 |
|
|
2023
Q4 | $16.7K | Buy |
506
+67
| +15% | +$1.9K | ﹤0.01% | 3531 |
|
|
2023
Q3 | $12K | Sell |
439
-105
| -19% | -$2.92K | ﹤0.01% | 3669 |
|
|
2023
Q2 | $16.5K | Sell |
544
-269
| -33% | -$8.7K | ﹤0.01% | 3635 |
|
|
2023
Q1 | $26.4K | Sell |
813
-69
| -8% | -$2.18K | ﹤0.01% | 3361 |
|
|
2022
Q4 | $24.8K | Sell |
882
-41
| -4% | -$1.18K | ﹤0.01% | 3362 |
|
|
2022
Q3 | $34K | Buy |
923
+537
| +139% | +$18.9K | ﹤0.01% | 3182 |
|
|
2022
Q2 | $12K | Buy |
386
+113
| +41% | +$3.29K | ﹤0.01% | 3721 |
|
|
2022
Q1 | $9K | Buy |
273
+185
| +210% | +$4.84K | ﹤0.01% | 3850 |
|
|
2021
Q4 | $3K | Sell |
88
-431
| -83% | -$12.4K | ﹤0.01% | 4063 |
|
|
2021
Q3 | $16K | Buy |
519
+394
| +315% | +$9.46K | ﹤0.01% | 3592 |
|
|
2021
Q2 | $3K | Buy |
125
+102
| +443% | +$2.04K | ﹤0.01% | 3978 |
|
|
2021
Q1 | $0 | Hold |
23
| – | – | ﹤0.01% | 4134 |
|
|
2020
Q4 | $0 | Hold |
23
| – | – | ﹤0.01% | 3991 |
|
|
2020
Q3 | $0 | Sell |
23
-28
| -55% | -$329 | ﹤0.01% | 3954 |
|
|
2020
Q2 | $0 | Sell |
51
-6,958
| -99% | -$46.6K | ﹤0.01% | 3949 |
|
|
2020
Q1 | $37K | Hold |
7,009
| – | – | ﹤0.01% | 2794 |
|
|
2019
Q4 | $64K | Hold |
7,009
| – | – | ﹤0.01% | 2747 |
|
|
2019
Q3 | $50K | Buy |
7,009
+23
| +0.3% | +$165 | ﹤0.01% | 2908 |
|
|
2019
Q2 | $55K | Sell |
6,986
-8,700
| -55% | -$103K | ﹤0.01% | 2885 |
|
|
2019
Q1 | $197K | Sell |
15,686
-3,074
| -16% | -$48.7K | ﹤0.01% | 2155 |
|
|
2018
Q4 | $373K | Buy |
18,760
+5,601
| +43% | +$130K | ﹤0.01% | 1707 |
|
|
2018
Q3 | $373K | Buy |
13,159
+4,908
| +59% | +$117K | ﹤0.01% | 1839 |
|
|
2018
Q2 | $174K | Buy |
8,251
+907
| +12% | +$17.2K | ﹤0.01% | 2269 |
|
|
2018
Q1 | $105K | Sell |
7,344
-8,078
| -52% | -$116K | ﹤0.01% | 2526 |
|
|
2017
Q4 | $191K | Buy |
15,422
+5,065
| +49% | +$71.4K | ﹤0.01% | 2220 |
|
|
2017
Q3 | $184K | Hold |
10,357
| – | – | ﹤0.01% | 2187 |
|
|
2017
Q2 | $262K | Buy |
10,357
+7,357
| +245% | +$177K | ﹤0.01% | 1983 |
|
|
2017
Q1 | $67K | Hold |
3,000
| – | – | ﹤0.01% | 2743 |
|
|
2016
Q4 | $44K | Buy |
3,000
+1,000
| +50% | +$19.7K | ﹤0.01% | 2887 |
|
|
2016
Q3 | $49K | Hold |
2,000
| – | – | ﹤0.01% | 2819 |
|
|
2016
Q2 | $38K | Hold |
2,000
| – | – | ﹤0.01% | 2953 |
|
|
2016
Q1 | $21K | Hold |
2,000
| – | – | ﹤0.01% | 3259 |
|
|
2015
Q4 | $24K | Hold |
2,000
| – | – | ﹤0.01% | 3200 |
|
|
2015
Q3 | $32K | Buy |
+2,000
| New | +$39K | ﹤0.01% | 3131 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
PNC Financial Services Group's EVH Position: Q1 2026 in Review
PNC Financial Services Group increased its Evolent Health (EVH) stake by 141% in Q1 2026, buying an estimated $11.2K and bringing the position to 6,041 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.
PNC Financial Services Group first reported a position in EVH in Q3 2015 and has held it in 43 quarters since. The position peaked at $373K in Q4 2018. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- PNC Financial Services Group held 6,041 shares of Evolent Health worth $13.8K as of Q1 2026.
- PNC Financial Services Group bought 3,537 Evolent Health shares in Q1 2026, an estimated $11.2K.
- Evolent Health made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3841 holding.
- PNC Financial Services Group first reported a position in Evolent Health in Q3 2015 and has held it in 43 quarters since.
- PNC Financial Services Group's Evolent Health position peaked at $373K in Q4 2018.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.